USANA Health Sciences Inc
NYSE:USNA

Watchlist Manager
USANA Health Sciences Inc Logo
USANA Health Sciences Inc
NYSE:USNA
Watchlist
Price: 33.94 USD 1.68% Market Closed
Market Cap: 646.9m USD
Have any thoughts about
USANA Health Sciences Inc?
Write Note

Wall Street
Price Targets

USNA Price Targets Summary
USANA Health Sciences Inc

Wall Street analysts forecast USNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for USNA is 47.43 USD with a low forecast of 35.35 USD and a high forecast of 60.9 USD.

Lowest
Price Target
35.35 USD
4% Upside
Average
Price Target
47.43 USD
40% Upside
Highest
Price Target
60.9 USD
79% Upside

USNA Last Price Targets
USANA Health Sciences Inc

The latest public price target was made on Oct 23, 2024 by Linda Bolton Weiser from D.A. Davidson , who expects USNA stock to rise by 3% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Linda Bolton Weiser
D.A. Davidson
35 USD
Upside 3%
2 months ago
Oct 23, 2024
USANA Health Sciences Inc. (USNA) PT Lowered to $35 at DA Davidson
StreetInsider
Linda Bolton Weiser
D.A. Davidson
38 USD
Upside 12%
4 months ago
Jul 25, 2024
Usana price target lowered to $38 from $46 at DA Davidson
TheFly
Linda Bolton Weiser
D.A. Davidson
46 USD
Upside 36%
7 months ago
May 7, 2024
USANA Health Sciences Inc. (USNA) PT Lowered to $46 at DA Davidson
StreetInsider
Linda Bolton Weiser
D.A. Davidson
Price Target 35 USD
Upside/Downside 3%
View Source
Linda Bolton Weiser
D.A. Davidson
Price Target 38 USD
Upside/Downside 12%
View Source
Linda Bolton Weiser
D.A. Davidson
Price Target 46 USD
Upside/Downside 36%
View Source
USANA Health Sciences Inc Competitors:
Price Targets
300146
By-health Co Ltd
18% Upside
BAJAJCON
Bajaj Consumer Care Ltd
36% Upside
KAREX
Karex Bhd
20% Upside
MED
Medifast Inc
0% Downside
PGHH
Procter & Gamble Hygiene and Health Care Ltd
20% Upside
051900
LG H&H Co Ltd
24% Upside
4927
Pola Orbis Holdings Inc
5% Downside
300791
Sirio Pharma Co Ltd
8% Upside

Revenue
Forecast

Revenue Estimate
USANA Health Sciences Inc

For the last 8 years the compound annual growth rate for USANA Health Sciences Inc's revenue is 0%. The projected CAGR for the next 3 years is -1%.

0%
Past Growth
-1%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
USANA Health Sciences Inc

For the last 8 years the compound annual growth rate for USANA Health Sciences Inc's operating income is -5%. The projected CAGR for the next 3 years is -13%.

-5%
Past Growth
-13%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
USANA Health Sciences Inc

For the last 8 years the compound annual growth rate for USANA Health Sciences Inc's net income is -5%. The projected CAGR for the next 3 years is -6%.

-5%
Past Growth
-6%
Estimated Growth
Estimates Accuracy
20%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is USNA's stock price target?
Price Target
47.43 USD

According to Wall Street analysts, the average 1-year price target for USNA is 47.43 USD with a low forecast of 35.35 USD and a high forecast of 60.9 USD.

What is USANA Health Sciences Inc's Revenue forecast?
Projected CAGR
-1%

For the last 8 years the compound annual growth rate for USANA Health Sciences Inc's revenue is 0%. The projected CAGR for the next 3 years is -1%.

What is USANA Health Sciences Inc's Operating Income forecast?
Projected CAGR
-13%

For the last 8 years the compound annual growth rate for USANA Health Sciences Inc's operating income is -5%. The projected CAGR for the next 3 years is -13%.

What is USANA Health Sciences Inc's Net Income forecast?
Projected CAGR
-6%

For the last 8 years the compound annual growth rate for USANA Health Sciences Inc's net income is -5%. The projected CAGR for the next 3 years is -6%.

Back to Top